Company profile: Biosynth
1.1 - Company Overview
Company description
- Provider of critical raw materials and services to the pharmaceutical and diagnostics industries, offering custom synthesis and manufacturing services. Focused on consolidating the fragmented supply chain to improve availability and reduce time-to-market for new therapies and diagnostic assays, increasing industry productivity.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biosynth
Explora BioLabs
HQ: United States
Website
- Description: Provider of preclinical, AAALAC-accredited vivarium rental facilities and contract vivarium operation services, delivering turnkey in vivo facilities, management, and related services for biopharmaceutical clients in biotech-dense areas, with vivarium management ensuring maintenance and compliance and CRO options to support early-stage research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Explora BioLabs company profile →
Ramarketing
HQ: United Kingdom
Website
- Description: Provider of marketing, advertising, public relations, SEO, content creation, graphic design, and consulting services for companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ramarketing company profile →
Aenova
HQ: United States
Website
- Description: Provider of pharmaceutical and healthcare services, including development, manufacturing and packaging of pharmaceuticals and dietary supplements across oral solids, semi-solids, liquids, sterile dosage forms, and soft gelatin and vegan soft capsules. Offers formulation, process and analytical development, stability studies, regulatory support, clinical trial management, animal health services, and biologics fill and finish for vials and prefilled syringes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aenova company profile →
DFE Pharma
HQ: Germany
Website
- Description: Provider of excipient solutions for pharmaceutical, biopharmaceutical, and nutraceutical industries, developing, producing, and supplying functional excipients used as fillers, binders, disintegrants, and stabilizers. Offers BioHale excipients to stabilize biologics across parenteral, inhalation, oral, and ophthalmic routes, an online formulation tool, and technical, regulatory, quality, and formulation support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DFE Pharma company profile →
EMD Millipore
HQ: United States
Website
- Description: Provider of biopharmaceutical manufacturing solutions including cell culture media, filtration and purification systems; life science research tools and reagents for genomic analysis, protein sample preparation, antibodies, assays and small molecule research; laboratory water purification systems and consumables; microbial testing for pharma, cosmetics, food, beverages and municipal water; IVD/OEM kits, materials and reagents; and chemicals, reagents and labware.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EMD Millipore company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biosynth
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biosynth
2.2 - Growth funds investing in similar companies to Biosynth
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biosynth
4.2 - Public trading comparable groups for Biosynth
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →